ARGORNA

Serial Number 79368771
Registration 7435586
700

Registration Progress

Application Filed
Dec 6, 2022
Under Examination
Approved for Publication
Apr 23, 2024
Published for Opposition
Apr 23, 2024
Registered
Jul 9, 2024

Trademark Image

ARGORNA

Basic Information

Serial Number
79368771
Registration Number
7435586
Filing Date
December 6, 2022
Registration Date
July 9, 2024
Published for Opposition
April 23, 2024
Drawing Code
5

Status Summary

Current Status
Active
Status Code
700
Status Date
Jul 9, 2024
Registration
Registered
Classes
005

Rights Holder

ARGORNA PHARMACEUTICALS CO., LTD

99
Address
2nd and 4th Floor, Building A, 7 Suida Street,
Huangpu District, Guangzhou Guangdong
CN

Ownership History

ARGORNA PHARMACEUTICALS CO., LTD

Original Applicant
99
CN

ARGORNA PHARMACEUTICALS CO., LTD

Owner at Publication
99
CN

ARGORNA PHARMACEUTICALS CO., LTD

Original Registrant
99
CN

Legal Representation

Attorney
Victoria Friedman

USPTO Deadlines

Next Deadline
1659 days remaining
Section 71 Declaration Due (Principal Register 66a) (Based on registration date 20240709)
Due Date
July 09, 2030
Grace Period Ends
January 09, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

28 events
Date Code Type Description Documents
Jan 10, 2025 FINO P FINAL DECISION TRANSACTION PROCESSED BY IB Loading...
Dec 20, 2024 FICS P FINAL DISPOSITION NOTICE SENT TO IB Loading...
Dec 20, 2024 FIMP P FINAL DISPOSITION PROCESSED Loading...
Oct 9, 2024 FICR P FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Loading...
Jul 9, 2024 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Jul 9, 2024 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Apr 30, 2024 GPNX P NOTIFICATION PROCESSED BY IB Loading...
Apr 23, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Apr 23, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Apr 10, 2024 OPNS P NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Loading...
Apr 10, 2024 OP2R P NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Loading...
Apr 3, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Mar 18, 2024 RFNT P REFUSAL PROCESSED BY IB Loading...
Mar 16, 2024 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Mar 14, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Mar 14, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Mar 14, 2024 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Feb 2, 2024 CNRT O NON-FINAL ACTION MAILED Loading...
Jan 11, 2024 CNRT R NON-FINAL ACTION WRITTEN Loading...
Oct 17, 2023 RFNT P REFUSAL PROCESSED BY IB Loading...
Sep 28, 2023 RFCS P NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Loading...
Sep 28, 2023 RFRR P REFUSAL PROCESSED BY MPU Loading...
Sep 18, 2023 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Loading...
Sep 17, 2023 CNRT R NON-FINAL ACTION WRITTEN Loading...
Sep 13, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
May 9, 2023 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
May 5, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
May 4, 2023 REPR M SN ASSIGNED FOR SECT 66A APPL FROM IB Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of tumor, asthma, arthritis, viral diseases, respiratory diseases, inflammation, fibrosis, hypertension, hyperlipidemia, cardiovascular diseases, eye diseases, angina, diabetes, and insomnia; vaccines; drugs for medical purposes, namely, pharmaceuticals for the treatment of tumor, asthma, arthritis, viral diseases, respiratory diseases, inflammation, fibrosis, hypertension, hyperlipidemia, cardiovascular diseases, eye diseases, angina, diabetes, and insomnia; biological preparations for medical purposes, for the treatment of tumor, asthma, arthritis, viral diseases, respiratory diseases, inflammation, fibrosis, hypertension, hyperlipidemia, cardiovascular diseases, eye diseases, angina, diabetes, and insomnia; medicines for human purposes; diagnostic preparations for medical purposes; chemical reagents for medical or veterinary purposes; reagent paper for medical purposes; raw material medicine, namely, insulin; biochemical medicines for the treatment of tumor, asthma, arthritis, viral diseases, respiratory diseases, inflammation, fibrosis, hypertension, hyperlipidemia, cardiovascular diseases, eye diseases, angina, diabetes, and insomnia

Classification

International Classes
005